Pet medication and supplies company suffers worst day in 23 years
- PetMed’s stock plunges 32.1% after disappointing quarterly results
- Company suspends dividend to save cash
- Stock on track for lowest close since 2004
- Dividend yield drops from 19% to zero
- Company aims to invest cash flow in higher return projects
Investors in PetMed Express Inc.’s stock are experiencing their worst day in 23 years as the company reported disappointing quarterly results and announced the suspension of its dividend to save cash. The stock plummeted 32.1%, putting it on track for the lowest close since 2004. The dividend cut follows a thorough analysis by the company’s Board of Directors and management team, who believe that investing the cash flow in higher return projects will be more beneficial. Despite adding 75,600 new customers during the quarter, PetMed is facing challenges in stabilizing its returning customer base. The company’s stock has dropped 64.8% year to date, while shares of Chewy Inc., a pet supplies and meds seller, have tumbled 47.6%.
Factuality Level: 7
Factuality Justification: The article provides information about PetMed Express Inc.’s disappointing quarterly results, suspension of dividend, and the reasons behind these decisions. It includes quotes from the company’s CEO and provides details about the financial performance of the company. The article also mentions the challenges faced by the company in stabilizing its customer base and the overall market conditions affecting the animal health industry. The information provided seems to be based on factual data and statements from the company’s representatives.
Noise Level: 3
Noise Justification: The article provides relevant information about PetMed Express Inc.’s disappointing quarterly results and decision to suspend its dividend. It includes quotes from the CEO and discusses the company’s financial performance. However, there is some repetitive information and the article does not provide a deep analysis or explore the consequences of the company’s decisions.
Financial Relevance: Yes
Financial Markets Impacted: Investors in PetMed Express Inc.’s stock
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Rating Justification: The article pertains to financial topics as it discusses the disappointing quarterly results and dividend suspension of PetMed Express Inc., which has led to a significant drop in the company’s stock. However, there is no mention of any extreme event or its impact.
Public Companies: PetMed Express Inc. (PETS), Chewy Inc. (CHWY)
Key People: Matt Hulett (Chief Executive), Jonathan Block (Stifel analyst)
Reported publicly:
www.marketwatch.com 
